mAbxience Beefs Up Its Biosimilar Production Capacity

AJMC: The Center for Biosimilars: Spanish biosimilar company mAbxience said it will equip its Good Manufacturing Practice–certified facility in Leon with a high-volume custom single-run 4000 L bioreactor, which it said will be installed and operational by mid-2021, thereby boosting the biosimilar and other biologics manufacturing capacity of the plant.

Read the article.